Combination of granulocyte colony-stimulating factor and CXCR4 antagonist AMD3100 for effective harvest of endothelial progenitor cells from peripheral blood and in vitro formation of primitive endothelial networks

详细信息    查看全文

• 作者：Wei-Li Fu ; Zhou Xiang ; Fu-Guo Huang ; Shi-Qiang Cen ; Gang Zhong…
• 关键词：Endothelial progenitor cells ; Circulating endothelial progenitor cells ; Stem cell mobilization peripheral blood stem cell transplantation
• 刊名：Cell and Tissue Banking
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：17
• 期：1
• 页码：161-169
• 全文大小：4,323 KB
• 参考文献：Amini AR, Laurencin CT, Nukavarapu SP (2012) Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering. J Orthop Res 30:1507–1515. doi:10.​1002/​jor.​22097 CrossRef PubMed
  Baudin B, Bruneel A, Bosselut N, Vaubourdolle M (2007) A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2:481–485. doi:10.​1038/​nprot.​2007.​54 CrossRef PubMed
  Boilson BA et al (2008) Endothelial progenitor cells exist in abundance in adipose tissue but not in peripheral blood. J Am Coll Cardiol 51:A295–A295
  Campanelli R et al (2010) G-Csf alone or in combination with chemotherapy does not mobilize endothelial progenitor cells into peripheral blood. Haematol-Hematol J 95:289
  Chen JK, Deng YP, Jiang GJ, Liu YZ, Zhao T, Shen FM (2013) Establishment of tube formation assay of bone marrow-derived endothelial progenitor cells. CNS Neurosci Ther 19:533–535. doi:10.​1111/​cns.​12102 CrossRef PubMed
  Damon LE, Damon LE (2009) Mobilization of hematopoietic stem cells into the peripheral blood. Expert Rev Hematol 2:717–733. doi:10.​1586/​ehm.​09.​54 CrossRef PubMed
  Das R, Jahr H, van Osch GJ, Farrell E (2010) The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng B Rev 16:159–168. doi:10.​1089/​ten.​TEB.​2009.​0296 CrossRef
  Dome B et al (2009) Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: from biology to therapy. Crit Rev Oncol Hemat 69:108–124. doi:10.​1016/​j.​critrevonc.​2008.​06.​009 CrossRef
  Duong HT, Erzurum SC, Asosingh K (2011) Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation. Angiogenesis 14:411–422. doi:10.​1007/​s10456-011-9228-y CrossRef PubMed PubMedCentral
  Grisar JC, Haddad F, Gomari FA, Wu JC (2011) Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomarkers Med 5:731–744. doi:10.​2217/​bmm.​11.​92 CrossRef
  Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, Simari RD (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93:1023–1025. doi:10.​1161/​01.​Res.​0000105569.​77539.​21 CrossRef PubMed
  Hirschi KK, Ingram DA, Yoder MC (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584–1595. doi:10.​1161/​ATVBAHA.​107.​155960 CrossRef PubMed
  Honold J et al (2006a) Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol 26:2238–2243. doi:10.​1161/​01.​ATV.​0000240248.​55172.​dd CrossRef PubMed
  Honold J et al (2006b) Effects of granulocyte colony stimulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Throm Vasc Biol 26:2238–2243. doi:10.​1161/​01.​Atv.​0000240248.​55172.​Dd CrossRef
  Hur J et al (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Throm Vasc Biol 24:288–293. doi:10.​1161/​01.​Atv.​0000114236.​77009.​06 CrossRef
  Ingram DA et al (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760. doi:10.​1182/​blood-2004-04-1396 CrossRef PubMed
  Kolonin MG, Simmons PJ (2009) Combinatorial stem cell mobilization. Nat Biotechnol 27:252–253. doi:10.​1038/​nbt0309-252 CrossRef PubMed
  Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM (2011) Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant 20:515–522. doi:10.​3727/​096368910X532729​ CrossRef PubMed PubMedCentral
  Llevadot J et al (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108:399–405. doi:10.​1172/​Jci13131 CrossRef PubMed PubMedCentral
  Martin-Ramirez J, Hofman M, van den Biggelaar M, Hebbel RP, Voorberg J (2012) Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc 7:1709–1715. doi:10.​1038/​nprot.​2012.​093 CrossRef PubMed
  Medina RJ, O’Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW (2010) Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics. doi:10.​1186/​1755-8794-3-18 PubMed PubMedCentral
  Peichev M et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952–958PubMed
  Pelus LM (2008) Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Curr Opin Hematol 15:285–292. doi:10.​1097/​MOH.​0b013e328302f43a​ CrossRef PubMed PubMedCentral
  Petit I et al (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687–694. doi:10.​1038/​ni813 CrossRef PubMed
  Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM (2009) Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4:62–72. doi:10.​1016/​j.​stem.​2008.​10.​017 CrossRef PubMed
  Pusic I, DiPersio JF (2010) Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol 17:319–326. doi:10.​1097/​MOH.​0b013e328338b7d5​ CrossRef PubMed
  Resch T, Pircher A, Kahler C, Pratschke J, Hilbe W (2012) Endothelial progenitor cells: current issues on characterization and challenging clinical applications. Stem Cell Rev Rep 8:926–939. doi:10.​1007/​s12015-011-9332-9 CrossRef
  Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo Vadis? J Mol Cell Cardiol 50:266–272. doi:10.​1016/​j.​yjmcc.​2010.​07.​009 CrossRef PubMed PubMedCentral
  Sen S, McDonald SP, Coates PT, Bonder CS (2011) Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 120:263–283. doi:10.​1042/​CS20100429 CrossRef
  Shepherd RM, Capoccia BJ, Devine SM, DiPersio J, Trinkaus KM, Ingram D, Link DC (2006) Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108:3662–3667. doi:10.​1182/​blood-2006-06-030577 CrossRef PubMed PubMedCentral
  Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87–102. doi:10.​1111/​j.​1582-4934.​2008.​00598.​x CrossRef PubMed PubMedCentral
  Toshner M et al (2009) Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 180:780–787. doi:10.​1164/​rccm.​200810-1662OC CrossRef PubMed PubMedCentral
  Tura O et al (2010) Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. J Throm Haemost JTH 8:1614–1623. doi:10.​1111/​j.​1538-7836.​2010.​03900.​x CrossRef
  Xue S, Zhang HT, Zhang P, Luo J, Chen ZZ, Jang XD, Xu RX (2010) Functional endothelial progenitor cells derived from adipose tissue show beneficial effect on cell therapy of traumatic brain injury. Neurosci Lett 473:186–191. doi:10.​1016/​j.​neulet.​2010.​02.​035 CrossRef PubMed
  Yoshioka T et al (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70:61–69. doi:10.​1016/​j.​cardiores.​2005.​12.​013 CrossRef PubMed
  Yuan Y, Altalhi WA, Ng JJ, Courtman DW (2013) Derivation of human peripheral blood derived endothelial progenitor cells and the role of osteopontin surface modification and eNOS transfection. Biomaterials 34:7292–7301. doi:10.​1016/​j.​biomaterials.​2013.​06.​003 CrossRef PubMed
  
• 作者单位：Wei-Li Fu (1)
  Zhou Xiang (1)
  Fu-Guo Huang (1)
  Shi-Qiang Cen (1)
  Gang Zhong (1)
  Xin Duan (1)
  Ming Liu (1)
  Frankie Leung (2)
  
  1. Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, 610041, China
  2. Department of Orthopaedics and Traumatology, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Cell Biology
  Biomedicine
  Transplant Surgery
  
• 出版者：Springer Netherlands
• ISSN：1573-6814

文摘

Endothelial progenitor cells (EPC) derived from the circulation may be used to enhance neovascularization. Since the combination of granulocyte colony-stimulating factor (GCSF) and CXCR4 antagonist AMD3100 efficiently mobilizes hematopoietic stem cells into peripheral circulation, it may increase the pool of endogenously circulating EPC. We tested this hypothesis by administering GCSF and AMD3100 to adult rabbits and rats, isolating mononuclear cells from peripheral blood by Ficoll density gradient centrifugation, and characterizing the blood-derived EPC based on morphology, immunophenotyping, gene expression and other functional analyses. These EPC showed clonal growth similar to that of human umbilical vein endothelial cells when cultured in complete EGM-2 medium on collagen I-precoated culture plates. The EPC exhibited a typical cobblestone-like morphology and were relatively homogeneous by the third passage. The cells expressed the typical endothelial marker CD31 based on flow cytometry and fluorescence microscopy, formed capillary-like structures when cultured in Matrigel, internalized DiI-acetylated low-density lipoprotein, bound Ulex europaeus agglutinin-1, and expressed CD31 and several other endothelial markers (VEGFR2, VE-cadherin, Tie-2, eNOS, vWF) at significantly higher levels than bone marrow-derived mesenchymal stem cells. These results suggest that the combination of GCSF and AMD3100 can efficiently release stem cells into peripheral circulation and generate EPC that show the desired morphological, immunophenotypic and functional characteristics. This minimally invasive approach may be useful for autologous cell transplantation for postnatal neovasculogenesis and tissue repair.